Lilly to Acquire Sigilon Therapeutics
INDIANAPOLIS and CAMBRIDGE, Mass., June 29, 2023 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) and Sigilon Therapeutics, Inc. (Nasdaq: SGTX) today announced a definitive agreement for Lilly to acquire Sigilon, a biopharmac... Biopharmaceuticals, Endocrinology, Mergers & Acquisitions Eli Lilly, Sigilon, encapsulated cell therapies (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 29, 2023 Category: Pharmaceuticals Source Type: news
K36 Therapeutics Announces $70 Million Series B Financing to Fund Clinical Proof of Concept of KTX-1001, First-in-class Inhibitor of MMSET for Treatment of Multiple Myeloma Patients with Genetic Translocation (4;14)
Funds raised will be used to demonstrate clinical validation and proof-of-concept in t(4;14) multiple myeloma with KTX-1001 monotherapy and KTX-1001 combination regimens with existing standard-of-care agents
CAMBRIDGE, Mass., June 28, 2023 -- (Healthcar... Biopharmaceuticals, Oncology, Venture Capital K36 Therapeutics, MMSET, multiple myeloma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 28, 2023 Category: Pharmaceuticals Source Type: news
SonoThera(TM) Expands Leadership Team Appointing Carolyne Zimmermann as Chief Business Officer
Zimmermann brings more than two decades of experience in business development, merger and acquisition strategy, deals and partnership development.
Prior to SonoThera, Zimmermann held senior leadership roles at Johnson & Johnson, Novartis and 4D Molecula... Biopharmaceuticals, Personnel SonoThera, sonoporation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 27, 2023 Category: Pharmaceuticals Source Type: news
Genesys Spine Launches SIros O(TM) Transfixing SI Joint Fusion System
AUSTIN, Texas, June 26, 2023 -- (Healthcare Sales & Marketing Network) -- Genesys Spine today announced the launch of the SIros O Oblique SI Fusion system. This is the third sacroiliac joint fusion system offered by Genesys Spine and provides physicians ... Devices, Neurosurgery, Orthopaedic, Product Launch Genesys Spine, SIros O, Oblique SI Fusion, SI Joint, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 26, 2023 Category: Pharmaceuticals Source Type: news
MEDICAL IP Received US FDA 510(k) Clearance for DeepCatch, AI Software for Whole-Body Composition CT Quantification
The world's first FDA cleared solution that automatically analyzes bone, muscle, visceral fat, subcutaneous fat, internal organ, and central nervous system in whole-body CT
Validation using multi-site and multi-racial CT data in the US
"We will cr... Devices, Radiology, FDA MEDICAL IP, DeepCatch, CT , AI software, imaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 26, 2023 Category: Pharmaceuticals Source Type: news
Regulus Therapeutics Announces Appointment of Preston S. Klassen, M.D. to its Board of Directors
SAN DIEGO, June 23, 2023 -- (Healthcare Sales & Marketing Network) -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or &q... Biopharmaceuticals, Personnel Regulus Therapeutics, microRNA, Autosomal Dominant Polycystic Kidney Disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 23, 2023 Category: Pharmaceuticals Source Type: news
Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics
Financing round led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture Fund, New Enterprise Associates, and Lightstone Ventures
Unique Click-to-Release platform enables on-target activation of antibody-drug conjugates (ADCs) ... Biopharmaceuticals, Oncology, Venture Capital Tagworks Pharmaceuticals, Click-to-Release platform, antibody-drug conjugates (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 22, 2023 Category: Pharmaceuticals Source Type: news
Intrinsic Therapeutics, Inc. Announces Positive Coverage Policy by Cigna Healthcare for Barricaid Bone-Anchored Annular Closure Device
BOSTON, June 21, 2023 -- (Healthcare Sales & Marketing Network) -- Intrinsic Therapeutics, Inc., a medical device company focused on preventing reherniation and reoperation following lumbar discectomy, announced today that Cigna Healthcare has issued a po... Devices, Neurosurgery, Orthopaedic, Reimbursement Intrinsic Therapeutics, Barricaid, discectomy, reherniation, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2023 Category: Pharmaceuticals Source Type: news
Aethlon Medical Announces Investigation of the Hemopurifier(R) for Use in Organ Transplantation
Research to Confirm the Hemopurifier's Ability to Remove Harmful Viruses and Exosomes From Harvested Organs
SAN DIEGO, June 21, 2023 -- (Healthcare Sales & Marketing Network) -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focuse... Devices Aethlon Medical, Hemopurifier (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2023 Category: Pharmaceuticals Source Type: news
Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology
INDIANAPOLIS and SOUTH SAN FRANCISCO, Calif., June 20, 2023 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) and DICE Therapeutics, Inc. (NASDAQ: DICE) today announced a definitive agreement for Lilly to acquire DICE.
DICE... Biopharmaceuticals, Mergers & Acquisitions Eli Lilly, DICE Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2023 Category: Pharmaceuticals Source Type: news
Sirnaomics Advances STP705 for Squamous Cell Carcinoma In Situ into Late-Stage Clinical Development
HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 19, 2023 -- (Healthcare Sales & Marketing Network) -- Sirnaomics Ltd. (the "Company"; stock code: 2257, together with its subsidiaries, the "Group" or "Sirnaomics"), a leadin... Biopharmaceuticals, Oncology Sirnaomics, RNAi therapeutics, squamous cell carcinoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2023 Category: Pharmaceuticals Source Type: news
VIVEX Biologics, Inc. Launches New CYGNUS(R) Dual Amniotic Allograft
New dual-layered amniotic allograft that supports healing and maintains inherent properties of amniotic tissue
MIAMI, June 16, 2023 -- (Healthcare Sales & Marketing Network) -- VIVEX Biologics, Inc., a leading regenerative medicine company specializing... Devices, Wound Care, Product Launch VIVEX Biologics, CYGNUS Dual, amniotic allograft (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 16, 2023 Category: Pharmaceuticals Source Type: news
Revolutionizing Cranial Neurosurgery: Novarad's VisAR Augmented Reality System Shatters Surgical Boundaries
SALT LAKE CITY, June 15, 2023 -- (Healthcare Sales & Marketing Network) -- Novarad, a trailblazer in innovative medical technology, is transforming the world of cranial neurosurgery with their augmented reality surgical navigation system. A recent study p... Devices, Neurosurgery Novarad , VisAR system, augmented reality (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 15, 2023 Category: Pharmaceuticals Source Type: news
RaySearch signs agreement with Shinva for large order in China
STOCKHOLM, June 15, 2023 -- (Healthcare Sales & Marketing Network) -- RaySearch Laboratories AB (publ) is pleased to announce an agreement with the Chinese radiation therapy machine manufacturer Shinva. Shinva has placed an order for 15 RayPlan®* syst... Devices, Oncology RaySearch, RayPlan, treatment planning system (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 15, 2023 Category: Pharmaceuticals Source Type: news
Carisma Therapeutics Appoints Eric Siegel as General Counsel and Corporate Secretary and Terry Shields as Senior Vice President of Human Resources
These new appointments expand the leadership team to support its legal and human resource sectors to ensure compliance and high quality employee experience
PHILADELPHIA, June 14, 2023 -- (Healthcare Sales & Marketing Network) -- Carisma Therapeutics In... Biopharmaceuticals, Oncology, Personnel Carisma Therapeutics, chimeric antigen receptor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 14, 2023 Category: Pharmaceuticals Source Type: news
